What Was the Infected Blood Scandal?
Between the 1970s and early 1990s, thousands of people in the United Kingdom were infected with HIV, Hepatitis C and other viruses after receiving NHS blood, blood products or tissue.
More than 3,000 deaths are attributable to what happened. People continue to live with the medical, psychological, social and financial consequences, while families continue to grieve those who died.
The infections were not simply an unavoidable tragedy. The Infected Blood Inquiry found a catalogue of individual, collective and systemic failures. It concluded that much of what happened could, and should, have been prevented.
Not one incident, but many connected failures
The term “infected blood scandal” can make what happened sound like a single contaminated batch or one disastrous decision.
It was neither.
People were infected at different haemophilia centres and other places, at different times and through different forms of blood-derived treatments. The decisions that exposed those infected to danger involved government departments, blood services, haemophilia centres, clinicians, regulators and pharmaceutical companies.
There were two principal routes of infection:
Blood products used to treat people with bleeding disorders such as haemophilia.
Blood transfusions given during surgery, childbirth and treatment for serious illness or injury.
These two different routes of infection are distinct from one another and comprise very different sets of factual matrix.
Factor VIII and Factor IX
People with haemophilia have reduced levels of proteins that allow blood to clot properly.
Haemophilia A is commonly treated by replacing Factor VIII. Haemophilia B is treated by replacing Factor IX.
Before the widespread introduction of concentrated factor blood products, patients were often treated with cryoprecipitate (Cryo). During the 1970s, Factor VIII and Factor IX concentrates became the norm for haemophilia treatment in the UK.
Some doctors, pharma companies and others argued that concentrated blood products were more convenient to use than Cryo, but the manufacturing process created an enormous and foreseeable viral risk.
Factor concentrates were made by combining plasma collected from thousands, and sometimes tens of thousands, of donors. If one donation carried a blood-borne virus, an entire batch would likely become contaminated. A single infected batch could then be given as finished product to many haemophilia patients.
As more and more concentrates were used, the poor decision-making to use such products was made even worse by the decision to import products rather than making them all in the UK from NHS blood donors. Significant volumes of commercial products were imported, particularly from the United States.
Some of the plasma used by commercial manufacturers had been collected from paid donors and from populations with a higher risk of blood-borne infection. This included plasma collected within American prisons and donors targeted due to their sexuality and previous hepatitis infection. The imported products were known to carry a particularly high risk of transmitting hepatitis.
The danger was not confined to imported products. UK-manufactured concentrates also transmitted viruses. Increasing the size of domestic plasma pools increased the likelihood that a single infected donation would contaminate an entire batch.
The Infected Blood Inquiry found that imported commercial concentrates were a principal source of HIV infection in the United Kingdom, but the scandal cannot be explained solely as a problem with American blood. It also involved domestic production, licensing, treatment policies, donor selection, delayed safety measures and failures within the NHS and government.
The risks were known
The central defence for decades was that nobody could have known what would happen. That defence has not survived the evidence.
The viruses were not always identifiable by name, but the danger was understood. It had been known since the 1940s that blood and plasma could transmit hepatitis. By the 1970s, doctors knew that a form then called non-A, non-B hepatitis was responsible for most post-transfusion hepatitis and could cause serious long-term liver disease. They also knew, since at least the 1950s, that pooling plasma from thousands of donors multiplied the opportunity for infection.
When AIDS became known about in the early 1980s, there was initially scientific uncertainty about its cause. There was not an absence of warning. By the middle of 1982, it was apparent that the agent responsible might be transmitted through blood and blood products. As the evidence mounted, the case for caution became overwhelming.
The institutions involved did not need perfect knowledge before taking protective action. They knew enough to reduce exposure, reconsider treatment policies, warn patients properly and move urgently towards safer products. Instead, dangerous treatments continued to be used, including on children and people who had received little or no previous treatment.
The warnings did not appear once and vanish. They accumulated across scientific papers, international meetings, internal correspondence and clinical experience. The failure was not that medicine could not predict the future. It was that known and emerging dangers were repeatedly tolerated, minimised or explained away while patients carried the consequences.
Patients were not told the truth
A patient cannot give meaningful consent if the most serious risks are withheld from them.
Across many haemophilia centres, people were treated with Factor VIII and Factor IX without being properly warned that the products would certainly transmit hepatitis and possibly HIV. Parents were not given the information they needed to make decisions for their children and in most cases, alternatives were never discussed. Reassurance was often given where honesty and caution were instead required.
The failures continued after infection. Patients were tested for HIV and, later, Hepatitis C without their knowledge or consent. Results were sometimes withheld or communicated years late. People were told casually, in groups, by letter or during an unrelated appointment. Some were not told at all until the infection had already caused serious damage.
This secrecy had consequences beyond the individual patient. People who did not know they were infected were denied the opportunity to seek treatment, protect their partners or make informed decisions about having children. Families were forced to live with consequences they had never been given the chance to understand, let alone accept.
These were not minor failures of bedside manner. They were violations of patient autonomy. The decision to accept a medical risk belonged to the patient, not to the doctor, the hospital or the state. By withholding information, clinicians took that decision away from the very people whose lives were at stake.
Unethical research on victims
Medical research can save lives but it also requires informed consent, independent scrutiny and an overriding duty to protect the individual patient. For the haemophilia community during the infected blood scandal, none of that happened.
Patients, including children, were enrolled in research without being properly told, or told at all, what was being studied or asked whether they agreed to take part. Blood was repeatedly taken and stored. Treatment, test results and infections were recorded for medical studies involving private research, arms of the state and pharmaceutical companies. The resulting data sometimes advanced medical knowledge and professional careers but the people whose bodies produced the data remained unaware that they had ever been research subjects or purposefully infected for the purposes of it.
Previously untreated patients were particularly valuable to researchers because doctors could observe what happened after their first exposure to blood products. That scientific value should have brought greater protection. Instead, it made some of the most vulnerable patients more useful as subjects of study.
The clearest example was Treloar’s, the specialist school attended by children with haemophilia. The Infected Blood Inquiry found that pupils were often regarded as objects for research rather than children whose treatment should be determined solely by their individual best interests. Multiple projects proceeded without informed consent. Children were exposed to different products and batches, including riskier commercial concentrates, while the viral dangers were not explained to them or their parents.
Treloar’s was the most notorious example, but it was not the only place where research was conducted without proper consent. In fact, most of the Unethical Research that took place did not take part there but in haemophilia centres around the country, including Oxford, Cardiff, Edinburgh and many others.
The value of anything learned is destroyed by the way it was obtained. Patients were not raw material. Children were not an opportunity to observe infection. The absence of informed consent made this research unethical, and no later publication can alter that fact.
How the truth was hidden
The word “cover-up” can suggest a single secret meeting or one coordinated instruction to conceal what happened. The reality was broader, messier and, in some ways, more disturbing. The Infected Blood Inquiry called it “hiding the truth”.
Patients were not told about risks, test results, alternative treatments or research carried out on them. Medical records went missing.
Important government files were lost or destroyed and death certificates often used vague language that concealed the role of HIV, hepatitis or contaminated treatment.
Government departments and health authorities developed defensive “lines to take”. Victims were repeatedly told that they had received the best treatment available, that infection had been unavoidable and that everything possible had been done as quickly as scientific knowledge allowed. The Inquiry found that these claims were false and repeatedly used without proper examination.
These are not theories about what might have happened, there are documented examples examined by the Infected Blood Inquiry.
The rewriting of the self-sufficiency report
In 2003, the Department of Health commissioned civil servant Peter Burgin to review the surviving documents about blood-product self-sufficiency. His original draft contained evidence that reflected badly on the Department and challenged the official account of why dangerous imported products had continued to be used.
Dianthus Medical was later contracted, ostensibly to improve the report’s referencing and add a summary. By the time the report was published in 2006, its substance had changed.
References to warnings in the 1970s about commercial concentrates being made from dangerous plasma sources such as prisons and hepatitis causing cirrhosis and liver cancer disappeared. A statement that viral infection was more likely with factor concentrates was rewritten. Passages showing the importance of safety concerns to the pursuit of self-sufficiency were removed or softened. New wording claimed that doctors had been careful to explain the risks to patients, despite the overwhelming evidence that many patients had not been properly warned.
The Inquiry found that the changes went far beyond editing or clarification and substantially altered the report’s meaning and conclusions. The final version reflected the defensive position adopted by government, not a balanced examination of what the documents showed.
The files that were supposedly already public
For years, ministers claimed that all relevant blood-safety documents up to 1995 were available through The National Archives. That assertion was also used to argue that a public inquiry would uncover nothing new.
Jason Evans tested the claim. Through Freedom of Information requests and the painstaking cross-referencing of departmental file numbers, he established that many files had not been transferred to the archives at all. Some were still being held by the Department of Health and other government departments.
Jason worked with Baroness Featherstone to place the evidence before Sir Chris Wormald, then Permanent Secretary at the Department of Health. In June 2018, Wormald apologised and accepted that ministers had been advised wrongly and had resultantly give incorrect information to parliament. The Department then began identifying what infected blood files it still held, what had already been transferred and what remained outside the public record.
This was not a minor correction. A central government argument against holding a public inquiry had been shown to be false.
The deliberate destruction of documents
Some important records were not merely misplaced.
Files belonging to the Advisory Committee on the Virological Safety of Blood, which considered the introduction of Hepatitis C screening, were deliberately destroyed. The Inquiry was explicit that this was not an accident, a flood, a fire or an administrative mishap. Somebody made the decision to destroy them.
The Inquiry concluded that it was more likely than not that the destruction was authorised because the files contained material concerning delays in introducing Hepatitis C screening in the UK. It described this as a deliberate attempt to make the truth more difficult to reveal.
Decades of refusing a public inquiry
Successive governments resisted a statutory public inquiry for decades. Ministers repeatedly claimed that all the relevant information was already public, that no wrongful practices had taken place and that an inquiry would add nothing.
Internal records told a different story. Officials knew that documents were missing and that important questions remained unanswered. Advice against an inquiry included concern that it would increase pressure for compensation and raise the profile of possible state responsibility.
The refusal to investigate relied on the government and civil service’s own assurances that an independent examination was unnecessary because nothing had been done wrong.
A statutory inquiry was finally announced in 2017. It proceeded to uncover extensive evidence that had never previously been seen or examined in public and concluded that the scandal could largely have been avoided.
This is what hiding the truth looked like in practice: documents destroyed, reports rewritten, false assurances repeated and an independent inquiry resisted until the political pressure became impossible to contain.
The human cost
The infected blood scandal cannot be measured only in infections, deaths or financial settlements. Its damage spread through entire families and across generations.
People being given treatment via the NHS were infected with HIV, Hepatitis C or both. Many became seriously ill while still young. Some endured liver failure, cancer and years of exhausting treatment. Hundreds died from AIDS at a time when the disease was widely misunderstood and brutally stigmatised. More than 3,000 deaths have been attributed to infected blood, blood products and tissue, and people continue to die from their infections today.
Stigma can be as cruel as the viruses themselves. Children were bullied at school and adults lost jobs, relationships and friendships. Families concealed diagnoses because they feared how neighbours, employers and even relatives might react. Some patients were refused treatment by dentists and other healthcare professionals. People already coping with a life-threatening infection were made to feel dangerous, shameful or responsible for something that had been done to them.
The harm did not stop with those who were infected. Family members became unpaid carers. Parents watched their children become ill and die as a result of treatment that, in many cases, they administered themselves - causing extreme feelings of guilt.
Children lost one or both parents. Families struggled with falling incomes, mounting debts and the practical demands of caring for someone whose health was deteriorating. Many bereaved relatives were then left to fight for answers while dealing with their own unresolved grief.
For decades, those families were also denied the truth. They were forced to live with unanswered questions, official denials and the suggestion that what had happened was an unavoidable medical accident. The original infections caused devastating physical harm and death but the secrecy, delay and institutional defensiveness that followed deepened that harm and prolonged it for generations.